* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Point of Care Testing and Microbiology
		                    
		                    
								Survey							
                            
		                
		                
                            
                            
								Document related concepts							
                        
                        
                    
						
						
							Transcript						
					
					Point of Care Testing and Microbiology Yvette S. McCarter, PhD, DABMM Director, Clinical Microbiology Laboratory University of Florida Health Science Center-Jacksonville Jacksonville, FL Clinical Associate Professor of Pathology University of Florida College of Medicine Point of Care Testing and Microbiology Objectives Historical Perspective  POCT – Clinically-relevant? Costeffective?  Currently available Microbiology POCT  Advantages and disadvantages of Microbiology POCT  Point of Care Testing Historical Perspective Clinical Ward Laboratory Testing Centralized Laboratory Testing Point of Care Testing Test Life Cycle Centralized Lab          Test ordered Test request processed Specimen obtained Specimen transported to lab Specimen processed by lab Specimen analyzed Results reviewed by lab staff Results reported to clinician Clinician acts on results Point of Care     Test ordered Specimen obtained Specimen analyzed Clinician acts on result Why is Point of Care testing a clinically relevant alternative to centralized testing? Decreased Turnaround Time Why decreased turnaround time? Elimination of specimen transport and processing time Transport/Processing Time vs. Analysis Time 40 35 TAT (min) 30 25 Analysis Time 20 Transport/Processing Time 15 10 5 0 Blood Gases K+/Na+ Hematocrit Salem et al. JAMA 1991; 266:382-389 Clinical Benefits of Decreased Turnaround Time Evidence-based medical decisions in “real time”  Eliminates need for ordering additional, unnecessary tests  Reduction in unneeded medications  Decrease in physician “switching”  Perceived patient benefits  Economic Considerations COST!!!! Look beyond “cost per test”  Judge cost-effectiveness in the context of “total cost of patient care”  Why is Point of Care testing a costeffective alternative to centralized testing? Decreased Turnaround Time Economic Benefits of Decreased Turnaround Time Reduction in duplicate test orders  Reduced consumption of other expensive services/products (lab tests, pharmaceuticals)  Decreased length of stay  Economic Benefits of Decreased Turnaround Time Point of Care Testing in the Post Anesthesia Care Unit  Use of POCT resulted in:  reduced test TAT from 26 min to 2 min  decreased length of stay by 18 min  documented cost savings due to decreased length of stay Goodwin MLO 1994; 26 (9S):15-18. Microbiology Point of Care Testing “Your scientists were so preoccupied with whether or not they could, they didn't stop to think if they should.” -Dr. Ian Malcolm Jurassic Park Why do we need it?       Evidence-based medical decisions in “real time” Eliminates need for ordering additional, unnecessary tests Reduction in unneeded medications “Perceived” patient benefits Reduction in duplicate test orders Reduced consumption of other expensive services/products (lab tests, pharmaceuticals) What to consider…    Choose the appropriate test  Difficulty?  Necessary skill level?  How much QC? Training  See one, do one, teach one Procedure  Don’t assume  Pictures Microbiology Point of Care Testing Most common  Group A streptococcal pharyngitis  Helicobacter pylori antibody  Helicobacter pylori  HIV antibody  Provider Performed Microscopy  Skin KOH  Vaginal KOH  Vaginal wet preps Microbiology Point of Care Testing Additional testing available  Influenza A, B and A/B  Infectious mononucleosis  Lyme antibody  Respiratory syncytial virus  Pinworm preps  Gram stain Group A Streptococcal Pharyngitis Acute pharyngitis=most frequent reason for pediatrician and PCP visits  Most pharyngitis viral in origin  Group A strep  15% of pharyngitis cases in children  Difficult to distinguish streptococcal and non-streptococcal disease  Group A Streptococcal Pharyngitis Group A Streptococcal Pharyngitis Group A Streptococcal Pharyngitis  Early recognition and treatment important  Shorten duration of clinical illness  Prevent transmission  Prevent sequelae  Rheumatic heart disease  Glomerulonephritis Group A Streptococcal Pharyngitis - Diagnosis Culture  Gold standard  24-48 hr result  Rapid antigen tests  Enzyme immunoassays (POCT)  Optical immunoassays  Nucleic acid based tests  Group A Streptococcal Pharyngitis - POCT Pediatric Setting  Evaluated 2401 patients with suspected streptococcal pharyngitis with rapid latex test and culture  Conclusions  Rapid test available while patient on-site  Same day Rx in 90% of patients Wiedermann et al. J Am Board Fam Pract 1991; 4:79-82 Group A Streptococcal Pharyngitis - POCT Emergency Department Compared clinical judgment vs. rapid testing for diagnosis of pharyngitis in 147 patients  Conclusions     Rapid test significantly better than clinical judgment for determining disease Rapid test eliminates problems/costs of empiric Rx and patient follow-up compliance Only 14% of patients followed up on cultures DuBois et al. Ann Emerg Med 1986; 15:157-159 Group A Streptococcal Pharyngitis - POCT Primary Care Setting Studied impact of rapid test on physician prescribing patterns  Conclusions    Antibiotic prescribing patterns changed when rapid test used Physicians initiated Rx with positive result and waited for culture before initiating Rx with negative result • Reduced inappropriate antibiotic usage • Reduced unnecessary cost and antibiotic exposure True et al. J Fam Prac 1986; 23:215-219 Group A Streptococcal Pharyngitis - POCT  37 CLIA “waived” tests  Abbott Signify  Biostar Acceava  Binax NOW  Quidel QuickVue  BD LINK  Meridian ImmunoCard Group A Streptococcal Pharyngitis - POCT  Advantages Results in 5 min  Internal controls  Clear endpoints   Disadvantages  Sensitivities lower than company claims Group A Streptococcal Pharyngitis - POCT  Things to remember…  Verification of test against culture  Culture all negative tests  Rapid test collection swab often different from culture swab Helicobacter pylori Infection   Early 1980s link between H. pylori and peptic ulcer disease/gastric cancer established Epidemiology  Up to 50% of world’s population infected  Fecal-oral and oral-oral spread  Prevalence of infection increases with age (developed countries) Helicobacter pylori Infection  Pathology Lives under protective mucous layer  Acute gastritis chronic active gastritis  Duodenal ulcer  MALT lymphoma  Gastric ulcer  Gastric carcinoma  Helicobacter pylori Infection Helicobacter pylori Diagnostic Methods  Noninvasive  Antibody detection  IgG (POCT)  IgA  Urea breath test  Stool antigen Helicobacter pylori Diagnostic Methods  Invasive  Biopsy (multiple required)  Histopathology • Silver or Warthin-Starry stains  Rapid urease testing (POCT) • Agar based gel or paper strip  Culture Helicobacter pylori POCT   Biopsy  7 CLIA “waived” tests  Serim PyloriTek  CLOtest  Chek-Med Systems HP One Serology  18 CLIA “waived” tests  Meridian ImmunoCard STAT  Abbott Signify  Quidel QuickVue Helicobacter pylori POCT Helicobacter pylori POCT Helicobacter pylori POCT Rapid Urease Testing  Advantages Rapid results  15 min-24 hr  Internal controls  Room temperature storage and incubation   Disadvantages  Potential for false negatives Helicobacter pylori POCT Antibody Detection  Advantages Rapid results  5 min  Built in controls  External controls  Room temperature storage   Disadvantages  Whole blood less sensitive than serum HIV Infection The Virus Retrovirus  Bar-shaped core  2 short strands of RNA  Enzymes       Reverse transcriptase Protease Ribonuclease Integrase Outer lipid envelope containing an antigen (gp160) that helps virus bind to CD4 cells A global view of HIV infection 33 million adults living with HIV/AIDS as of end 1999 Adult prevalence rate 15.0% – 36.0% 5.0% – 15.0% 1.0% – 5.0% 0.5% – 1.0% 0.1% – 0.5% 0.0% – 0.1% not available Diagnosis of HIV    Culture  Rarely performed Serology - Gold Standard  Sensitive EIA  Confirmatory Western blot Window period  P24 antigen  PCR Diagnosis of HIV  Alternative Fluids and Home Collection  OraSure  Oral mucosal transudate - serum derived fluid, enters saliva from gingival crevices, contains antibody • Can be used for EIA and Western blot testing, comparable sensitivity to serum  Calypte (Sentinel)  Urine • Lower sensitivity and specificity than serum for diagnosis • No FDA licensed Western blot  Home Access    Finger stick, mail in blood spot for testing Pre and post test counseling Problem with improperly collected specimens Diagnosis of HIV - POCT  1 CLIA “waived” test  OraQuick Rapid HIV-1 Antibody Test Diagnosis of HIV - POCT Public Health Setting Evaluated 1923 samples from STD clinics and HIV counseling centers using SUDS and conventional EIA / WB  Conclusions    SUDS sensitivity 100%, PPV 88% (STD), PPV 81% (HIV) Rapid testing feasible in public health settings (accurate, reasonable cost, results during visit) Kassler et al. J Clin Microbiol 1995: 33:2899-2902 Diagnosis of HIV - POCT  Labor and Delivery  Evaluated 380 women presenting with unknown HIV status  Compared OraQuick performed in L&D and lab  Conclusions  Median TAT POCT=45 min, lab=3.5 hr  More rapid implementation of antiviral Rx with POCT MMWR 2003; 52:866-868 Diagnosis of HIV - POCT  Appropriate settings  Evaluation of needlestick exposures  Labor and Delivery  Previously untested for HIV  Public Health  STD clinics  HIV counseling centers  ED Diagnosis of HIV - POCT  Advantages Rapid results  Counseling  Rx  Internal controls  Accurate   Disadvantages Must confirm positive results  “Restrictions”  Diagnosis of HIV - POCT Restrictions  Sale restricted to clinical laboratories      that have an adequate QA program; and where there is assurance operators will receive and use instructional materials Approved only for use by an agent of a clinical laboratory Test subjects must receive “Subject Information” prior to collection and appropriate information when results are provided Not approved to screen blood or tissue donors Diagnosis of HIV - POCT  Things to think about…  Can a central lab give you adequate TAT?  Who will be doing the testing?  What about positives?  PT  RHIVW (CAP) Provider Performed Microscopy  Things to think about…  Training and continued proficiency  Pictures  Use of “live” specimens  Microscope Conclusions Decide first if test needs to be done at point of care  Pick the right test  Keep in mind the manual nature of the testing 
 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                            